{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T19:58:09Z","timestamp":1772308689610,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Fight for Sight"},{"name":"Illinois Society for the Prevention of Blindness"},{"name":"Dr. John P. and Therese E. Mulcahy Endowed Professorship in Ophthalmology"},{"name":"Richard A. Perritt M.D. Charitable Foundation"},{"name":"Felix and Carmen Sabates Missouri Endowed Chair in Vision Research"},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY015672"],"award-info":[{"award-number":["EY015672"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Experimentica Ltd."},{"name":"K&P Scientific LLC"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.jtos.2019.02.006","type":"journal-article","created":{"date-parts":[[2019,2,25]],"date-time":"2019-02-25T04:10:15Z","timestamp":1551067815000},"page":"257-264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Manganese(III) tetrakis(1-methyl-4-pyridyl) porphyrin, a superoxide dismutase mimetic, reduces disease severity in in vitro and in vivo models for dry-eye disease"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3102-2213","authenticated-orcid":false,"given":"Agn\u0117","family":"\u017diniauskait\u0117","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3559-5476","authenticated-orcid":false,"given":"Symantas","family":"Ragauskas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita K.","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rubina","family":"Thapa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne E.","family":"Roessler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Koulen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giedrius","family":"Kalesnykas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenni J.","family":"Hakkarainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6878-521X","authenticated-orcid":false,"given":"Simon","family":"Kaja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtos.2019.02.006_bib1","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","article-title":"TFOS DEWS II epidemiology report","volume":"15","author":"Stapleton","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2019.02.006_bib2","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II definition and classification report","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2019.02.006_bib3","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/bjophthalmol-2015-307415","article-title":"Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction","volume":"100","author":"Baudouin","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jtos.2019.02.006_bib4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.4155\/cli.14.135","article-title":"Cyclosporine ophthalmic emulsions for the treatment of dry eye: a review of the clinical evidence","volume":"5","author":"Ames","year":"2015","journal-title":"Clin Investig (Lond)"},{"key":"10.1016\/j.jtos.2019.02.006_bib5","series-title":"Restasis (cyclosporine ophthalmic emulsion) 0.05%, application number 21-023, approval letter","author":"Department of Health and Human Services, Food and Drug Administration","year":"2000"},{"key":"10.1016\/j.jtos.2019.02.006_bib6","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1001\/jama.2016.12872","article-title":"Lifitegrast (Xiidra) for dry eye disease","volume":"317","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jtos.2019.02.006_bib7","series-title":"Xiidra (lifitegrast ophthalmic solution) 5%, application number 208073, approval letter","author":"Deaprtment of Health and Human Services, Food and Drug Administration","year":"2016"},{"key":"10.1016\/j.jtos.2019.02.006_bib8","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","article-title":"TFOS DEWS II management and therapy report","volume":"15","author":"Jones","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2019.02.006_bib9","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/ICO.0000000000000803","article-title":"Safety of lifitegrast ophthalmic solution 5.0% in patients with dry eye disease: a 1-year, multicenter, randomized, placebo-controlled study","volume":"35","author":"Donnenfeld","year":"2016","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2019.02.006_bib10","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00417-014-2853-6","article-title":"Evaluation of oxidative stress levels in the conjunctival epithelium of patients with or without dry eye, and dry eye patients treated with preservative-free hyaluronic acid 0.15 % and vitamin B12 eye drops","volume":"253","author":"Macri","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jtos.2019.02.006_bib11","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.3109\/02713683.2015.1098707","article-title":"Expression of lipid peroxidation markers in the tear film and ocular surface of patients with non-sjogren syndrome: potential biomarkers for dry eye disease","volume":"41","author":"Choi","year":"2016","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jtos.2019.02.006_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045805","article-title":"Oxidative stress induced inflammation initiates functional decline of tear production","volume":"7","author":"Uchino","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jtos.2019.02.006_bib13","article-title":"Oxidative stress markers induced by hyperosmolarity in primary human corneal epithelial cells","volume":"10","author":"Deng","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jtos.2019.02.006_bib14","doi-asserted-by":"crossref","first-page":"4727415","DOI":"10.1155\/2016\/4727415","article-title":"Therapeutic efficacy of topically applied antioxidant medicinal plant extracts in a mouse model of experimental dry eye","volume":"2016","author":"Choi","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.jtos.2019.02.006_bib15","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1167\/iovs.16-20634","article-title":"Anti-inflammatory and antioxidative effects of camellia japonica on human corneal epithelial cells and experimental dry eye: in vivo and in vitro study","volume":"58","author":"Lee","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2019.02.006_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exer.2014.05.001","article-title":"Reactive oxygen species activated NLRP3 inflammasomes prime environment-induced murine dry eye","volume":"125","author":"Zheng","year":"2014","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2019.02.006_bib17","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/ICO.0000000000000543","article-title":"Effects of quercetin in a mouse model of experimental dry eye","volume":"34","author":"Oh","year":"2015","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2019.02.006_bib18","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1523\/JNEUROSCI.21-13-04582.2001","article-title":"Neuroprotection from delayed postischemic administration of a metalloporphyrin catalytic antioxidant","volume":"21","author":"Mackensen","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.jtos.2019.02.006_bib19","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2337\/diabetes.51.2.347","article-title":"A metalloporphyrin-based superoxide dismutase mimic inhibits adoptive transfer of autoimmune diabetes by a diabetogenic T-cell clone","volume":"51","author":"Piganelli","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.jtos.2019.02.006_bib20","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0891-5849(02)00980-2","article-title":"A small molecular weight catalytic metalloporphyrin antioxidant with superoxide dismutase (SOD) mimetic properties protects lungs from radiation-induced injury","volume":"33","author":"Vujaskovic","year":"2002","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jtos.2019.02.006_bib21","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0891-5849(00)00194-5","article-title":"Manganese-porphyrin reactions with lipids and lipoproteins","volume":"28","author":"Bloodsworth","year":"2000","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jtos.2019.02.006_bib22","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1021\/tx980245d","article-title":"Catalytic scavenging of peroxynitrite by isomeric Mn(III) N-methylpyridylporphyrins in the presence of reductants","volume":"12","author":"Ferrer-Sueta","year":"1999","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.jtos.2019.02.006_bib23","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0891-5849(98)00261-5","article-title":"Metalloporphyrins are potent inhibitors of lipid peroxidation","volume":"26","author":"Day","year":"1999","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jtos.2019.02.006_bib24","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1177\/1091581813490203","article-title":"A nonclinical safety assessment of MnTE-2-PyP, a manganese porphyrin","volume":"32","author":"Gad","year":"2013","journal-title":"Int J Toxicol"},{"key":"10.1016\/j.jtos.2019.02.006_bib25","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00403-016-1693-0","article-title":"Topically applied manganese-porphyrins BMX-001 and BMX-010 display a significant anti-inflammatory response in a mouse model of allergic dermatitis","volume":"308","author":"Stover","year":"2016","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jtos.2019.02.006_bib26","first-page":"614","article-title":"An SV40-immortalized human corneal epithelial cell line and its characterization","volume":"36","author":"Araki-Sasaki","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2019.02.006_bib27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijpharm.2016.06.135","article-title":"Acute cytotoxic effects of marketed ophthalmic formulations on human corneal epithelial cells","volume":"511","author":"Hakkarainen","year":"2016","journal-title":"Int J Pharm"},{"key":"10.1016\/j.jtos.2019.02.006_bib28","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.exer.2015.05.023","article-title":"Plate reader-based cell viability assays for glioprotection using primary rat optic nerve head astrocytes","volume":"138","author":"Kaja","year":"2015","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jtos.2019.02.006_bib29","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.12659\/MSM.899699","article-title":"Glioprotection of retinal astrocytes after intravitreal administration of memantine in the mouse optic nerve crush model","volume":"23","author":"Maciulaitiene","year":"2017","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.jtos.2019.02.006_bib30","first-page":"2942","article-title":"Culture model of human corneal epithelium for prediction of ocular drug absorption","volume":"42","author":"Toropainen","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2019.02.006_bib31","first-page":"257","article-title":"A mouse dry eye model induced by topical administration of benzalkonium chloride","volume":"17","author":"Lin","year":"2011","journal-title":"Mol Vis"},{"key":"10.1016\/j.jtos.2019.02.006_bib32","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1167\/iovs.18-24432","article-title":"Efficacy of trabodenoson in a mouse keratoconjunctivitis sicca (KCS) model for dry-eye syndrome","volume":"59","author":"Ziniauskaite","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2019.02.006_bib33","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat Methods"},{"key":"10.1016\/j.jtos.2019.02.006_bib34","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s13346-016-0330-y","article-title":"Human corneal cell culture models for drug toxicity studies","volume":"6","author":"Ronkko","year":"2016","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.jtos.2019.02.006_bib35","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1167\/iovs.08-2239","article-title":"Genomic aberrations and cellular heterogeneity in SV40-immortalized human corneal epithelial cells","volume":"50","author":"Yamasaki","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2019.02.006_bib36","first-page":"632","article-title":"A mouse model of keratoconjunctivitis sicca","volume":"43","author":"Dursun","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2019.02.006_bib37","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jtos.2012.04.001","article-title":"Nuclear Factor-kappaB: central regulator in ocular surface inflammation and diseases","volume":"10","author":"Lan","year":"2012","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2019.02.006_bib38","doi-asserted-by":"crossref","first-page":"5632","DOI":"10.1167\/iovs.12-9547","article-title":"Expression of toll-like receptor 4 contributes to corneal inflammation in experimental dry eye disease","volume":"53","author":"Lee","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2019.02.006_bib39","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00726-010-0603-6","article-title":"Design of Mn porphyrins for treating oxidative stress injuries and their redox-based regulation of cellular transcriptional activities","volume":"42","author":"Batinic-Haberle","year":"2012","journal-title":"Amino Acids"},{"issue":"Suppl 1","key":"10.1016\/j.jtos.2019.02.006_bib40","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1097\/ICO.0b013e31826a5de1","article-title":"A new mouse model of dry eye disease: oxidative stress affects functional decline in the lacrimal gland","volume":"31","author":"Uchino","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2019.02.006_bib41","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s12325-015-0274-5","article-title":"SkQ1 ophthalmic solution for dry eye treatment: results of a phase 2 safety and efficacy clinical study in the environment and during Challenge in the controlled adverse environment model","volume":"33","author":"Petrov","year":"2016","journal-title":"Adv Ther"}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012418302337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012418302337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:34:57Z","timestamp":1761539697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542012418302337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S1542012418302337"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2019.02.006","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Manganese(III) tetrakis(1-methyl-4-pyridyl) porphyrin, a superoxide dismutase mimetic, reduces disease severity in in vitro and in vivo models for dry-eye disease","name":"articletitle","label":"Article Title"},{"value":"The Ocular Surface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtos.2019.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}